| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6016112 | Epilepsy Research | 2012 | 9 Pages |
Abstract
DEVA acts in rats as a prodrug of VPA yet shows a more potent anticonvulsant activity than VPA. DEVAMIDE acted as the drug on its own and was more potent than DEVA at the rat-MES test.
Related Topics
Life Sciences
Neuroscience
Neurology
Authors
Tawfeeq Shekh-Ahmad, Meir Bialer, Eylon Yavin,